TD Asset Management
ALPN

TD Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

TD Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-118,418
Closed -$4.69M – 1448
2024
Q1 		$4.69M Buy
118,418
+85,218
+257% +$2.51M ﹤0.01% 789
2023
Q4 		$633K Buy
+33,200
New +$461K ﹤0.01% 1269

TD Asset Management's ALPN Position: Q2 2024 in Review

TD Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 118,418 shares — an estimated $4.69M sold.

TD Asset Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $4.69M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • TD Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • TD Asset Management sold 118,418 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.69M.
  • TD Asset Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • TD Asset Management's Alpine Immune Sciences Inc position peaked at $4.69M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.